U.S. FDA panel votes against approval for Nektar's opioid painkiller

Independent advisers to the U.S. Food and Drug Administration on Tuesday unanimously voted against Nektar Therapeutics' opioid painkiller for adults with chronic low back pain for whom currently available therapies have been inadequate.